Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Orphan drug designation for 17-AAG in multiple myeloma

Oct. 25, 2004

Chugai presents novel benzothiophene-based FTase inhibitors

Oct. 25, 2004

Oncolytics Biotech reports on Reolysin

Oct. 22, 2004

Phase I study for INSM-18 in relapsed prostate cancer patients

Oct. 22, 2004

Pfizer researchers design new protein kinase inhibitors

Oct. 22, 2004

LFM-A13 effective in model of graft-versus-host disease

Oct. 21, 2004

Patient dosing begins for oral forodesine hydrochloride in phase I study

Oct. 21, 2004

Roche researchers identify new uPA antagonists for use in cancer therapy

Oct. 21, 2004

New photosensitizer isolated from plant extract by AIST scientists

Oct. 21, 2004

Second phase I study for SNS-595

Oct. 20, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...